- Report
- August 2022
- 115 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- January 2024
- 249 Pages
Global
€4546EUR$4,995USD£3,861GBP
- Report
- September 2023
- 270 Pages
Global
€4364EUR$4,795USD£3,707GBP
- Report
- January 2025
- 99 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- April 2024
- 93 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- February 2022
- 97 Pages
Global
From €3200EUR$3,766USD£2,813GBP
The Sterile Injectable Drugs market is a segment of the Pharmaceuticals industry that focuses on the production and distribution of sterile injectable drugs. These drugs are typically administered intravenously, intramuscularly, or subcutaneously and are used to treat a variety of medical conditions. Sterile injectable drugs are highly regulated and must meet stringent safety and quality standards.
The market is driven by the increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases, as well as the growing demand for biologics and biosimilars. Additionally, the rising demand for self-administered injectable drugs, such as insulin, is expected to drive the market.
Some of the major companies in the Sterile Injectable Drugs market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more